Insider Transactions Reported by 19 Insiders of Provention Bio, Inc.

Location
Red Bank, NJ

Sponsored

Quick Takeaways

  • Provention Bio, Inc. has 19 insiders with reported activity on this page.
  • No net insider buy/sell flow is currently reported for the last year.
  • Recent transaction rows are not currently available.

What Changed

  • No meaningful buy/sell imbalance is currently visible in the one-year window.
  • Activity will update as new Forms 3/4/5 are filed.

Why This Matters

  • This page gives a plain-language issuer insider context before you inspect transaction-level evidence.
  • Use the filing links below to verify timestamps, codes, and ownership impacts directly from SEC forms.

Official SEC Source

Filed on Form 4

Issuer insider activity is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Insider trading overview

Last 12 months

Insider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 12 Apr 2025.

Buys

$0

Shares: 0

Insiders: 0

Sells

$0

Shares: 0

Insiders: 0

Net

$0

Shares: 0

Insiders: 0

Window (months) Buy shares Sell shares Buy $ Sell $ Net $
0-3 0 0 $0 $0 $0
3-6 0 0 $0 $0 $0
6-9 0 0 $0 $0 $0
9-12 0 0 $0 $0 $0

Provention Bio, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Valuation Report Date
Avery W. Catlin Director $243,200 Mixed 27 Apr 2023
Drechsler Andrew T. Chief Financial Officer Mixed 12 May 2021
Wayne Pisano Director Mixed 27 Apr 2023
Rita Jain Director Mixed 27 Apr 2023
John Kenneth Jenkins Director Mixed 27 Apr 2023
Sessa Capital (Master), L.P. 10%+ Owner Mixed 27 Apr 2023
Francisco Leon Chief Scientific Officer Mixed 27 Apr 2023
Sean M. Doherty Director Mixed 17 May 2022
Jeffrey A. Bluestone Director Mixed 17 May 2022
Sarah O'Brien Chief People Officer Mixed 10 Jan 2023
Jason Hoitt Chief Commercial Officer Mixed 27 Apr 2023
Heidy King-Jones Chief Legal Officer Mixed 27 Apr 2023
Thierry Chauche Chief Financial Officer Mixed 27 Apr 2023
Eleanor Ramos Chief Medical Officer Mixed 27 Apr 2023
Nancy Wysenski Director Mixed 27 Apr 2023
Justin Vogel Chief Accounting Officer Mixed 27 Apr 2023
Miyoko Christina Yi Chief Operations Officer Mixed 27 Apr 2023
Ashleigh Palmer Director and CEO Mixed 27 Apr 2023
Benedict Osorio Chief Quality Officer Mixed 27 Apr 2023

Top shareholders of Provention Bio, Inc. (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
Avery W. Catlin
3/4/5
Director —
class O/S missing
10,000
 $243,200 — 27 Apr 2023
3/4/5
Drechsler Andrew T.
3/4/5
Chief Financial Officer —
class O/S missing
139,500
 — — 12 May 2021
3/4/5
Sarah O'Brien
3/4/5
Chief People Officer —
class O/S missing
100,000
 — — 10 Jan 2023
3/4/5
Jeffrey A. Bluestone
3/4/5
Director —
class O/S missing
33,000
 — — 17 May 2022
3/4/5
Sean M. Doherty
3/4/5
Director —
class O/S missing
33,000
 — — 17 May 2022
3/4/5

Recent Insider Transactions by Companies or Individuals for Provention Bio, Inc.

Showing up to 300 most recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
No insider transactions were found in the last 12 months for this issuer.
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Sponsored